Cargando…

Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions

[Image: see text] Triethylphosphinegold(I) complexes [Au(HL1)P(CH(2)CH(3))(3)]PF(6) (1), [Au(HL2)P(CH(2)CH(3))(3)]PF(6) (2), and [Au(HL3)P(CH(2)CH(3))(3)]PF(6) (3) were obtained with (E)-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)hydrazinecarbothioamide (HL1), (E)-N-methyl-2-(1-(2-meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Ana P. A., Freitas, Jennifer T. J., Diniz, Renata, Pessoa, Claudia, Maranhão, Sarah S., Ribeiro, Juliana M., Souza-Fagundes, Elaine M., Beraldo, Heloisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033962/
https://www.ncbi.nlm.nih.gov/pubmed/32095716
http://dx.doi.org/10.1021/acsomega.9b03778
_version_ 1783499780179099648
author Oliveira, Ana P. A.
Freitas, Jennifer T. J.
Diniz, Renata
Pessoa, Claudia
Maranhão, Sarah S.
Ribeiro, Juliana M.
Souza-Fagundes, Elaine M.
Beraldo, Heloisa
author_facet Oliveira, Ana P. A.
Freitas, Jennifer T. J.
Diniz, Renata
Pessoa, Claudia
Maranhão, Sarah S.
Ribeiro, Juliana M.
Souza-Fagundes, Elaine M.
Beraldo, Heloisa
author_sort Oliveira, Ana P. A.
collection PubMed
description [Image: see text] Triethylphosphinegold(I) complexes [Au(HL1)P(CH(2)CH(3))(3)]PF(6) (1), [Au(HL2)P(CH(2)CH(3))(3)]PF(6) (2), and [Au(HL3)P(CH(2)CH(3))(3)]PF(6) (3) were obtained with (E)-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)hydrazinecarbothioamide (HL1), (E)-N-methyl-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)hydrazinecarbothioamide (HL2), and (E)-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)-N-phenylhydrazinecarbothioamide (HL3). All compounds were assayed for their cytotoxic activities against HCT-116 colorectal carcinoma cells under normoxia and hypoxia conditions and against nonmalignant HEK-293 human embryonic kidney cells under normoxia conditions. The thiosemicarbazone ligands HL1-HL3 were inactive against HCT-116 cells under hypoxia but while HL3 was inactive, HL1 and HL2 proved to be cytotoxic to both cell lineages under normoxia conditions. Complexes (1–3) and the triethylphosphinegod(I) precursor proved to be active against both cell lineages in normoxia as well as in hypoxia. While 1 and 3 revealed to be active against HEK-293 and HCT-116 cells, being approximately as active against HCT-116 cells in normoxia as under hypoxia, complex (2) proved to be more active against HCT-116 cells under hypoxia than under normoxia conditions, and more active against HCT-116 cells than against the nonmalignant HEK-293 cells, with the selectivity index, calculated as SI = IC(50HEK-293)/IC(50HCT-116hypoxia), equal to 3.7, similar to the value obtained for the control drug tirapazamine (tirapazamine (TPZ), SI = 4). Although the compounds showed distinct cytotoxic activities, the electrochemical behaviors of HL1-HL3 were very similar, as were the behaviors of complexes (1–3). Complex (2) deserves special interest since it was significantly more active under hypoxia than under normoxia conditions. Hence, in this case, selective reduction of the nitro group in a low oxygen pressure environment, resulting in toxic reactive oxygen species (ROS) and damage to DNA or other biomolecules, might operate, while for the remaining compounds, other modes of action probably occur.
format Online
Article
Text
id pubmed-7033962
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-70339622020-02-24 Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions Oliveira, Ana P. A. Freitas, Jennifer T. J. Diniz, Renata Pessoa, Claudia Maranhão, Sarah S. Ribeiro, Juliana M. Souza-Fagundes, Elaine M. Beraldo, Heloisa ACS Omega [Image: see text] Triethylphosphinegold(I) complexes [Au(HL1)P(CH(2)CH(3))(3)]PF(6) (1), [Au(HL2)P(CH(2)CH(3))(3)]PF(6) (2), and [Au(HL3)P(CH(2)CH(3))(3)]PF(6) (3) were obtained with (E)-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)hydrazinecarbothioamide (HL1), (E)-N-methyl-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)hydrazinecarbothioamide (HL2), and (E)-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)-N-phenylhydrazinecarbothioamide (HL3). All compounds were assayed for their cytotoxic activities against HCT-116 colorectal carcinoma cells under normoxia and hypoxia conditions and against nonmalignant HEK-293 human embryonic kidney cells under normoxia conditions. The thiosemicarbazone ligands HL1-HL3 were inactive against HCT-116 cells under hypoxia but while HL3 was inactive, HL1 and HL2 proved to be cytotoxic to both cell lineages under normoxia conditions. Complexes (1–3) and the triethylphosphinegod(I) precursor proved to be active against both cell lineages in normoxia as well as in hypoxia. While 1 and 3 revealed to be active against HEK-293 and HCT-116 cells, being approximately as active against HCT-116 cells in normoxia as under hypoxia, complex (2) proved to be more active against HCT-116 cells under hypoxia than under normoxia conditions, and more active against HCT-116 cells than against the nonmalignant HEK-293 cells, with the selectivity index, calculated as SI = IC(50HEK-293)/IC(50HCT-116hypoxia), equal to 3.7, similar to the value obtained for the control drug tirapazamine (tirapazamine (TPZ), SI = 4). Although the compounds showed distinct cytotoxic activities, the electrochemical behaviors of HL1-HL3 were very similar, as were the behaviors of complexes (1–3). Complex (2) deserves special interest since it was significantly more active under hypoxia than under normoxia conditions. Hence, in this case, selective reduction of the nitro group in a low oxygen pressure environment, resulting in toxic reactive oxygen species (ROS) and damage to DNA or other biomolecules, might operate, while for the remaining compounds, other modes of action probably occur. American Chemical Society 2020-02-06 /pmc/articles/PMC7033962/ /pubmed/32095716 http://dx.doi.org/10.1021/acsomega.9b03778 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Oliveira, Ana P. A.
Freitas, Jennifer T. J.
Diniz, Renata
Pessoa, Claudia
Maranhão, Sarah S.
Ribeiro, Juliana M.
Souza-Fagundes, Elaine M.
Beraldo, Heloisa
Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions
title Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions
title_full Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions
title_fullStr Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions
title_full_unstemmed Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions
title_short Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions
title_sort triethylphosphinegold(i) complexes with secnidazole-derived thiosemicarbazones: cytotoxic activity against hct-116 colorectal cancer cells under hypoxia conditions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033962/
https://www.ncbi.nlm.nih.gov/pubmed/32095716
http://dx.doi.org/10.1021/acsomega.9b03778
work_keys_str_mv AT oliveiraanapa triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions
AT freitasjennifertj triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions
AT dinizrenata triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions
AT pessoaclaudia triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions
AT maranhaosarahs triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions
AT ribeirojulianam triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions
AT souzafagundeselainem triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions
AT beraldoheloisa triethylphosphinegoldicomplexeswithsecnidazolederivedthiosemicarbazonescytotoxicactivityagainsthct116colorectalcancercellsunderhypoxiaconditions